ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646127 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646127; 2) Community: the network communities that were significantly associated with the response to NSC 646127; 3) Molecule: the relationships between components within communities and NSC 646127; 4) MDR: the compounds that were significantly associated with the NSC 646127.

NSC Compound Enrichment Correlation
NSC 704637 Null 0.0100995289754787 -0.11153367
NSC 705437 Null 0.0100995289754787 0.025542967
NSC 737132 6-Propyl-2,3-methylenedioxy-8,9-methylenedioxy-11H-indeno-1, 2-c]isoquinolinium Nonaflate 0.0100995289754787 0.50611799
NSC 740564 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0100995289754787 0.034946812
NSC 125845 Null 0.0100995289754788 0.010729608
NSC 3088 Chlorambucil 0.0100995289754788 -0.0087806992
NSC 609699 Topotecan hydrochloride 0.0100995289754788 0.25123904
NSC 610458 Camptothecin Derivative 0.0100995289754788 0.10054784
NSC 610459 Camptothecin Derivative 0.0100995289754788 0.21443613
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0100995289754788 0.16687958
Total:78  Current:19    [First] [Prev] [Next] [Last]